Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease
| Autor: | Erik Taal, Michiel E. de Jong, Frank Hoentjen, Ellen Slotman, Jeroen M. Jansen, Pepijn W. A. Thomas, Maurice G. Russel, Rachel L. West, Tessa E H Römkens |
|---|---|
| Přispěvatelé: | Psychology, Health & Technology |
| Rok vydání: | 2021 |
| Předmět: |
Crohn’s disease
Cross-Cultural Comparison medicine.medical_specialty Disease Inflammatory bowel disease digestive system Severity of Illness Index 03 medical and health sciences PROMs 0302 clinical medicine Internal medicine Surveys and Questionnaires Medicine Humans Patient Reported Outcome Measures ulcerative colitis Netherlands Crohn's disease business.industry IBD-control Gastroenterology Outcome measures Reproducibility of Results medicine.disease Inflammatory Bowel Diseases Ulcerative colitis female genital diseases and pregnancy complications digestive system diseases 030220 oncology & carcinogenesis Quality of Life 030211 gastroenterology & hepatology Patient-reported outcome Colitis Ulcerative business Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5] |
| Zdroj: | Scandinavian Journal of Gastroenterology, 56, 2, pp. 155-161 Scandinavian Journal of Gastroenterology, 56, 155-161 Scandinavian Journal of Gastroenterology, 56(2), 155-161. Informa Healthcare |
| ISSN: | 0036-5521 |
| Popis: | Contains fulltext : 235614.pdf (Publisher’s version ) (Open Access) BACKGROUND: There is a need for easy-to-use patient-reported outcome measures (PROMS) in inflammatory bowel disease (IBD) practice. The 'IBD-control' is a short IBD-specific questionnaire capturing disease control from the patient's perspective. The International Consortium for Health Outcomes Measurement (ICHOM) recommends the use of the IBD-control even though it has only been validated in the United Kingdom. We aimed to cross-culturally translate and validate the IBD-control in the Netherlands using IBDREAM, a prospective multicentre IBD registry. METHODS: Lack of ambiguity and acceptability were verified in a pilot patient group (n = 5) after forward-backward translation of the IBD-control. Prospective validation involved completion of the IBD-control, Short Form-36, short IBDQ and disease activity measurement by Physician Global Assessment (PGA) and Simple Clinical Colitis Activity Index or Harvey-Bradshaw Index. Test-retest (2-week repeat) was used for measuring reliability. RESULTS: Questionnaires were completed by 998 IBD patients (674 Crohn's disease, 324 ulcerative colitis). Internal consistency (Cronbach's alpha) was 0.82 for the sub-group of 8 questions (IBD-control-8-sub-score). Mean completion time was 105 s. Construct validity analyses demonstrated moderate-to-strong correlations of the IBD-control-8-subscore and the other instruments (0.49-0.81). Test-retest reliability for stable patients was high (intraclass correlation coefficient 0.95). The IBD-control-8-subscore showed good discriminant ability between the PGA categories (ANOVA, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|